Silvestri A - Search Results

1

Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.

Vitale C, Gebara O, Mercuro G, Wajngarten M, Silvestri A, Rossini P, Ramires JA, Fini M, Rosano GM. Vitale C, et al. Among authors: silvestri a. Maturitas. 2005 Apr 11;50(4):239-46. doi: 10.1016/j.maturitas.2003.09.032. Maturitas. 2005. PMID: 15780522 Clinical Trial.

2

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response.

Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA, Fini M, Mercuro G, Rosano GM. Silvestri A, et al. Circulation. 2003 Jul 1;107(25):3165-9. doi: 10.1161/01.CIR.0000074208.02226.5E. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796135 Clinical Trial.

3

In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.

Vitale C, Cerquetani E, Wajngarten M, Leonardo F, Silvestri A, Mercuro G, Fini M, Ramires JA, Rosano GM. Vitale C, et al. Among authors: silvestri a. Ital Heart J. 2003 Sep;4(9):627-32. Ital Heart J. 2003. PMID: 14635381

4

Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection.

Rosano GM, Vitale C, Silvestri A, Fini M. Rosano GM, et al. Among authors: silvestri a. Maturitas. 2003 Dec 10;46 Suppl 1:S17-29. doi: 10.1016/j.maturitas.2003.09.015. Maturitas. 2003. PMID: 14670642 Review.

5

Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.

Silvestri A, Gambacciani M, Vitale C, Monteleone P, Ciaponi M, Fini M, Genazzani AR, Mercuro G, Rosano GM. Silvestri A, et al. Maturitas. 2005 Apr 11;50(4):305-11. doi: 10.1016/j.maturitas.2004.07.012. Maturitas. 2005. PMID: 15780531 Clinical Trial.

6

Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial.

Gambacciani M, Monteleone P, Vitale C, Silvestri A, Fini M, Genazzani AR, Rosano GM. Gambacciani M, et al. Among authors: silvestri a. Maturitas. 2002 Oct 25;43(2):117-23. doi: 10.1016/s0378-5122(02)00184-6. Maturitas. 2002. PMID: 12385860 Clinical Trial.

7

Hormone replacement therapy and cardioprotection: the end of the tale?

Rosano GM, Vitale C, Silvestri A, Fini M. Rosano GM, et al. Among authors: silvestri a. Ann N Y Acad Sci. 2003 Nov;997:351-7. doi: 10.1196/annals.1290.038. Ann N Y Acad Sci. 2003. PMID: 14644842 Review.

8

Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke.

Silvestri A, Vitale C, Ferretti F, Onorati D, Fini M, Rosano GM. Silvestri A, et al. J Am Geriatr Soc. 2004 Sep;52(9):1586-7. doi: 10.1111/j.1532-5415.2004.52430_7.x. J Am Geriatr Soc. 2004. PMID: 15341576 No abstract available.

9

Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.

Vitale C, Cornoldi A, Gebara O, Silvestri A, Wajngarten M, Cerquetani E, Fini M, Ramires JA, Rosano GM. Vitale C, et al. Among authors: silvestri a. Menopause. 2005 Sep-Oct;12(5):552-8. doi: 10.1097/01.gme.0000172267.24949.70. Epub 2005 Sep 1. Menopause. 2005. PMID: 16145309 Clinical Trial.

10

The metabolic syndrome in women: implications for therapy.

Rosano GM, Vitale C, Silvestri A, Fini M. Rosano GM, et al. Among authors: silvestri a. Int J Clin Pract Suppl. 2004 Mar;(139):20-5. Int J Clin Pract Suppl. 2004. PMID: 15117109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

725 results

Search Page

Filters